By
Pfizer front runner to clinch Strides Arcolab’s specialty biz for $1.7B
Pfizer

Global pharmaceutical manufacturer Pfizer is in advanced talks with Strides Arcolab to buy its specialty business housing injectable drug unit for $1.7 billion (Rs 9,460 crore), three people with ...

TO READ THE FULL STORY


Leave Your Comment(s)